Reportlinker Adds Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies.

NEW YORK, June 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies

utm_campaign=Drug_and_

Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies

Summary

GBI Research's report, "Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies", provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effects of counterfeits on the pharmaceutical industry in the US, Europe and the Rest of the World. Further, the report provides an analysis on the technologies and solutions that are used to eliminate or prevent counterfeiting of drugs. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes -

- Challenges facing the pharmaceutical industry

- Sources of counterfeiting in the pharmaceutical industry

- Analysis of the impact of counterfeiting in the pharmaceutical industry

- Key technologies and solutions that are developed to reduce counterfeiting .

- Competitive benchmarking of leading technology solutions companies in the market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Assess impact of counterfeiting on pharmaceutical sales, distribution and other functions

- Identify solutions and technologies that are useful against counterfeiting of drugs

- Identify best practices in the industry through analyses of solutions developed by industry leaders

- Strengthen security of supply chain through case studies of implementation of technologies.

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 7

2 Impact of Counterfeits on Pharmaceutical Industry - Introduction 8

2.1 GBI Research Report Guidance 9

3 Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting in the Pharmaceutical Industry 10

3.1 Introduction 10

3.2 Extent of the Problem - A Global Scenario 11

3.3 Counterfeits and Pharmaceutical Distribution Chains 14

3.3.1 Possible Access Points of Counterfeit Medicines into Legitimate Distribution Channels 14

3.4 Targets for Counterfeits 18

3.4.1 Bulk Ingredients 18

3.4.2 Finished Products 18

3.4.3 Examples of Counterfeiting (2005-2009) 21

3.5 Factors Encouraging the Counterfeiting of Pharmaceuticals 24

3.5.1 High Profits and Low Risk in Counterfeiting (Relatively Small Risk and Low Penalty) 24

3.5.2 Rising Demand for the Prescription and Lifestyle Drugs 25

3.5.3 Proliferation of Online Drug Sale Channels 25

3.5.4 Price Controls by the Government 26

3.5.5 Availability of Sophisticated Tools for Counterfeiting 26

3.5.6 Deregulation and Lack of Tools for Law Implementation 26

3.5.7 Lack of Awareness among Patients 27

4 Impact of Counterfeits on Pharmaceutical Industry - Countries and Counterfeiting of Pharmaceuticals 28

4.1 Developed countries 28

4.1.1 The US 28

4.1.2 Canada 29

4.1.3 Europe 30

4.1.4 Developing Countries 31

5 Impact of Counterfeits on Pharmaceutical Industry - Global Initiatives Against Counterfeiting in Pharmaceuticals 37

5.1 Key Challenges to Fight against Counterfeits 37

5.2 Anti-Counterfeit Platforms 37

5.2.1 WHO and International Medical Products Anti-Counterfeiting Taskforce (IMPACT) 37

5.2.2 European Alliance for Access to Safe Medicines (EAASM) 39

5.2.3 European Federation of Pharmaceutical Industries and Associations (EFPIA) 40

5.2.4 Pharmaceutical Security Institute (PSI) 41

5.2.5 Verified Internet Pharmacy Practice Sites (VIPPS) 43

5.2.6 Verified-Accredited Wholesale Distributors Program (VAWD) 44

5.2.7 The US FDA 44

5.2.8 China 45

5.2.9 India 46

5.2.10 Russia 46

5.2.11 Africa 47

5.2.12 Pharmaceutical Industry 47

6 Impact of Counterfeits on Pharmaceutical Industry - Anti-Counterfeiting Strategies 49

6.1 Introduction 49

6.2 Overt (Visible) Technologies 50

6.2.1 Holograms/Diffractive Optical Elements 50

6.2.2 Optical Variable Device (OVD) 51

6.2.3 Sequential Product Numbering 51

6.2.4 Security Graphics 51

6.2.5 On Product Marking 51

6.2.6 Color Shifting Security Inks and Films 51

6.2.7 Film Wrappers 51

6.2.8 Shrink Seals and Bands 51

6.2.9 Breakable Caps 51

6.2.10 Sealed Tubes 51

6.3 Covert (Hidden) Technologies 52

6.3.1 Invisible Printing and Watermarks 52

6.3.2 Hidden Marks and Printing 52

6.4 Forensic Markers 52

6.4.1 Chemical Taggants 53

6.4.2 DNA Fragments 53

6.4.3 Micro-Particle Taggants (Nanotaggants) 53

6.4.4 Isotope Ratio 53

6.5 Mass Serialization/Track and Trace Technologies 53

6.5.1 Serialization 54

7 Impact of Counterfeits on Pharmaceutical Industry - Parallel Trade in Pharmaceutical Distributions 57

7.1 Introduction 57

7.2 General Pathway of Parallel Trade 57

7.3 Factors Encouraging Parallel Trade in Pharmaceuticals 59

7.3.1 Drug Price Difference across Various Pharmaceutical Markets 60

7.3.2 Government Price Controls Policy 62

7.3.3 Supportive Legal and Regulatory Framework to Parallel Trade in Medicines 62

7.3.4 Availability of Multiple Importation Pharmaceutical Markets 62

7.4 Parallel Trade in Pharmaceuticals - A Controversial Issue 63

7.4.1 Research and Development 64

7.4.2 Product Shortage 64

7.4.3 Parallel Trade and Benefits to Patients 64

7.4.4 Product Recall 65

7.4.5 Counterfeit Medicines 65

7.5 European Parallel Trade - Current Perspectives 66

7.5.1 Price Differences in Europe 69

7.5.2 Legal and Regulatory Framework Supporting Parallel Trade in Medicines 72

7.5.3 Opposition to Parallel Trade in Medicines in Europe 73

7.5.4 The UK 74

7.5.5 Germany 76

7.5.6 Sweden 77

7.5.7 Spain 77

7.5.8 Greece 78

7.6 Parallel Trade in the US Pharmaceutical Market 78

7.6.1 Parallel Trade and the FDA's Perspective 79

8 Impact of Counterfeits on Pharmaceutical Industry - Impact Analysis of Counterfeit Medicine and Parallel Trade in Pharmaceutical Distribution 81

8.1 Impact of Counterfeit Medicines 81

8.1.1 Impact of Counterfeit Medicines on Patients 81

8.1.2 Impact of Counterfeit Medicines on Drug Manufacturers 83

8.1.3 Impact of Counterfeit Medicines on Governments 84

8.2 Impact of Parallel Trade in Pharmaceutical Distribution 86

8.2.1 Parallel Trade Reduces Revenue and Incentives to Invest in Research and Development 87

8.2.2 Pharmaceutical Companies May Delay or Refrain From the Launch of New Products Due to the Impact of Parallel Trade 87

8.2.3 Parallel Trade Hinders Effective Batch Recall 87

8.2.4 Product Shortage 87

8.2.5 Human Error in Repackaging Undermines Efficacy of Medicines 88

8.2.6 Product Stability can be Hampered by Repackaging of Drug Products 88

8.2.7 Price 89

8.3 Counterfeit Medicines and Parallel Trade in Pharmaceuticals 89

9 Impact of Counterfeits on Pharmaceutical Industry - Appendix 91

9.1 Market Definitions 91

9.2 Abbreviations 91

9.3 Research Methodology 95

9.3.1 Coverage 95

9.3.2 Secondary Research 95

9.3.3 Primary Research 95

9.3.4 Expert Panel Validation 96

9.4 Contact Us 96

9.5 Disclaimer 96

9.6 Sources 97

List of Tables

1.1 List of Tables

Table 1: Impact of Counterfeits, Issued Drug Alerts Related to Counterfeit Medicines, 2005-2009 21

Table 2: Impact of Counterfeits, Examples of Counterfeit Medicines, 2005-2009 21

Table 3: Impact of Counterfeits, Prevalence of Counterfeit Medicines in Developed Countries 28

Table 4: Impact of Counterfeits, Prevalence of Counterfeit Medicines in Developing Countries 32

Table 5: Impact of Counterfeits, Verified Internet Pharmacy Practice Sites 43

Table 6: Impact of Counterfeits, Pros and Cons of Overt Features 50

Table 7: Impact of Counterfeits, Pros and Cons of Covert Features 52

Table 8: Impact of Counterfeits, Pros and Cons of Forensic Markers 52

Table 9: Impact of Counterfeits, Pros and Cons of Track and Trace Technologies 53

Table 10: Impact of Counterfeits, Drug Price Difference by Country, 2009 61

Table 11: Impact of Counterfeits, Short and Long Term Effects of Parallel Trade 63

Table 12: Impact of Counterfeits, Share of Parallel Trade in the Pharmaceutical Industry, Europe, (%), 2005-2008 67

Table 13: Impact of Counterfeits, Pricing and Reimbursement Methodologies in Selected EU Countries 70

List of Figures

1.2 List of Figures

Figure 1: Impact of Counterfeits, Counterfeit Medicine, Key Facts 10

Figure 2: Impact of Counterfeits, Number of Incidents of Counterfeiting by Region, 2009 12

Figure 3: Impact of Counterfeits, Global, Number of Incidents of Counterfeiting, 2002-2009 13

Figure 4: Impact of Counterfeits, Possible Access Points of Counterfeits in the Legitimate Drug Distribution Chain 14

Figure 5: Impact of Counterfeits, Reasons for Purchasing Medicines From Online Pharmacies 15

Figure 6: Impact of Counterfeits, Targets for Counterfeits, 2009 19

Figure 7: Impact of Counterfeits, Factors Encouraging the Counterfeiting of Pharmaceuticals 24

Figure 8: Impact of Counterfeits, Lack of Awareness Among Patients about Medicines 27

Figure 9: Impact of Counterfeits, Access Points of Counterfeits in the US Drug Supply Chain 28

Figure 10: Impact of Counterfeits, Product Verification at the Point of Dispense Flow Chart 40

Figure 11: Impact of Counterfeits, PSI Members 41

Figure 12: Impact of Counterfeits, Quantity of Fake Medicines Seized, (%), 2009 42

Figure 13: Impact of Counterfeits, Arrest Data for Counterfeiters, (%), 2009 42

Figure 14: Impact of Counterfeits, General Parallel Trade Pathway 58

Figure 15: Impact of Counterfeits, Factors Encouraging Parallel Trade 59

Figure 16: Impact of Counterfeits, Lipitor Price Difference by Country, 2009 60

Figure 17: Impact of Counterfeits, Nexium Price Difference by Country, 2009 61

Figure 18: Impact of Counterfeits, Share of Parallel Trade in the Pharmaceutical Industry, Europe, 2008 66

Figure 19: Impact of Counterfeits, Share of Parallel Trade in the Pharmaceutical Industry, Europe, 2005-2008 67

Figure 20: Impact of Counterfeits, Share of Parallel Trade in the Total European Pharmaceutical Industry, 2005-2008 68

Figure 21: Impact of Counterfeits, Plavix Price Difference by Country, 2009 69

Figure 22: Impact of Counterfeits, Share of Parallel Trade in Germany, 2008 76

Figure 23: Impact of Counterfeits, Impact of Counterfeiting of Drugs on Patients 81

Figure 24: Impact of Counterfeits, Effect of Counterfeiting of Drugs on Pharmaceutical Companies 83

Figure 25: Impact of Counterfeits, Effect of Counterfeiting of Drugs on Governments 84

Figure 26: Impact of Counterfeits, Negative Impact of Parallel Trade 86

Figure 27: Impact of Counterfeits, Complex Network of Parallel Trade in Europe 89

To order this report:

Drug and Medication Industry: Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies

Drug and Medication Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker